NO164897C - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES. - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES.

Info

Publication number
NO164897C
NO164897C NO862439A NO862439A NO164897C NO 164897 C NO164897 C NO 164897C NO 862439 A NO862439 A NO 862439A NO 862439 A NO862439 A NO 862439A NO 164897 C NO164897 C NO 164897C
Authority
NO
Norway
Prior art keywords
oxazolidinon
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO862439A
Other languages
Norwegian (no)
Other versions
NO862439D0 (en
NO164897B (en
NO862439L (en
Inventor
Walter Klose
Gerald Kirsch
Andreas Huth
Wolfgang Froehlich
Henry Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO862439D0 publication Critical patent/NO862439D0/en
Publication of NO862439L publication Critical patent/NO862439L/en
Publication of NO164897B publication Critical patent/NO164897B/en
Publication of NO164897C publication Critical patent/NO164897C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B1/00Engines characterised by fuel-air mixture compression
    • F02B1/02Engines characterised by fuel-air mixture compression with positive ignition
    • F02B1/04Engines characterised by fuel-air mixture compression with positive ignition with fuel-air mixture admission into cylinder
NO862439A 1984-10-19 1986-06-18 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES. NO164897C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843438839 DE3438839A1 (en) 1984-10-19 1984-10-19 PHARMACEUTICAL PREPARATIONS
PCT/DE1985/000472 WO1986002268A1 (en) 1984-10-19 1985-10-18 Pharmaceutical preparations

Publications (4)

Publication Number Publication Date
NO862439D0 NO862439D0 (en) 1986-06-18
NO862439L NO862439L (en) 1986-06-18
NO164897B NO164897B (en) 1990-08-20
NO164897C true NO164897C (en) 1990-11-28

Family

ID=6248597

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862439A NO164897C (en) 1984-10-19 1986-06-18 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES.

Country Status (8)

Country Link
EP (1) EP0198919B1 (en)
JP (2) JPH0742229B2 (en)
AU (2) AU5095885A (en)
DE (2) DE3438839A1 (en)
DK (1) DK167531B1 (en)
FI (1) FI862590A0 (en)
NO (1) NO164897C (en)
WO (1) WO1986002268A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles
DE3639225A1 (en) * 1986-11-14 1988-05-19 Schering Ag USE OF 5- (SUBST. PHENYL) -OXAZOLIDINONE DERIATES AS PSYCHOPHARMAKA
WO1988009661A1 (en) * 1987-06-10 1988-12-15 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
ATE106243T1 (en) * 1988-03-24 1994-06-15 Sankyo Co USE OF ISOXAZOLINONES AS CEREBRO-ACTIVE MEDICATIONS.
US5420154A (en) * 1990-08-03 1995-05-30 Smithkline Beecham Corp. TNF inhibitors
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
HUP9702408A3 (en) * 1995-02-10 2000-08-28 Schering Ag Use of 5-phenyloxazolidin-2-one derivatives for the preparation of pharmaceutical compositions treating diseases requiring tumour necrosis factor (tnf) inhibition
DE19540475A1 (en) * 1995-10-20 1997-04-24 Schering Ag Chiral methylphenyloxazolidinones
US6770658B2 (en) * 1998-09-09 2004-08-03 Inflazyme Pharmaceuticals Ltd. Substituted γ-phenyl-Δ-lactams and uses related thereto
DE60233884D1 (en) * 2001-10-16 2009-11-12 Memory Pharmaceutical Corp 4 (4-ALKOXY-3-HYDROXYPHENYL) -2-PYRROLIDONE DERIVATIVES AS PDE-4 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL SYNDROMES
WO2004098592A1 (en) * 2003-05-06 2004-11-18 Senju Pharmaceutical Co. Ltd. Composition containing oxazolidinone derivative
AR057218A1 (en) 2005-12-15 2007-11-21 Astra Ab OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413935A1 (en) * 1974-03-20 1975-10-16 Schering Ag 4- (POLYALCOXY-PHENYL) -2-PYRROLIDONE
SU888821A3 (en) * 1976-12-03 1981-12-07 Шеринг Аг (Инофирма) Method of preparing 5-(substituted phehyl)-oxazolidinones or their sulphur-containing analogs
DE2655369A1 (en) * 1976-12-03 1978-06-08 Schering Ag 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION

Also Published As

Publication number Publication date
NO862439D0 (en) 1986-06-18
JPH0761978A (en) 1995-03-07
DK288686D0 (en) 1986-06-19
AU5095885A (en) 1986-05-02
JP2669494B2 (en) 1997-10-27
NO164897B (en) 1990-08-20
DE3576118D1 (en) 1990-04-05
DK288686A (en) 1986-06-19
FI862590A (en) 1986-06-17
NO862439L (en) 1986-06-18
JPS62501289A (en) 1987-05-21
DE3438839A1 (en) 1986-04-24
DK167531B1 (en) 1993-11-15
EP0198919A1 (en) 1986-10-29
AU4765390A (en) 1990-05-03
WO1986002268A1 (en) 1986-04-24
JPH0742229B2 (en) 1995-05-10
FI862590A0 (en) 1986-06-17
EP0198919B1 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
NO163406C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOKINOLINO DERIVATIVES.
NO167142C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HETEROCYCLIC DERIVATIVES.
NO862477D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-ARYLIMIDAZOLE DERIVATIVES.
NO864126D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDON DERIVATIVES.
NO853046L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE INDOL DERIVATIVES.
NO871266D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES.
NO164165C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOTETRALIN DERIVATIVES.
NO162514C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHILD DERIVATIVES.
NO167384C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-ARALKYL PIPERIDINE-METHANOL DERIVATIVES.
NO870526D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE DICHLORANILIN DERIVATIVES.
NO165239C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-BENZYL-AMINOALKYL-PYRROLIDINON DERIVATIVES.
NO165192C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GLYCLE DERIVATIVES.
NO164097C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2- (N-SUBSTITUTED-GUANIDINO) -4-HETERO-ARYL-TIAZOL DERIVATIVES.
NO874032D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CATECHOLD DERIVATIVES.
NO152129C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OMEGA-CYAN-1, OMEGA-DIFENYL-AZAALKANDER DERIVATIVES
NO168355C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZIMIDAZOLD DERIVATIVES
NO161562C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ERGOLIN DERIVATIVES.
NO164897C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXAZOLIDINON DERIVATIVES.
NO161559C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRIAZOLD DERIVATIVES.
NO158941C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-PIPERIDINO-CHINAZOLINE DERIVATIVES.
NO160079C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM DERIVATIVES.
NO862372D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLO DERIVATIVES.
NO165069C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPENTYLETERS.
NO158739C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES.
NO161313C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORALLYLAMINE DERIVATIVES.